Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Leica biosystems recently became aware that in various lots the primary antibodies to cd2 (clone 11f11) and cd7 (clone lp15) have been adulterated. based on their investigations the product labelled as cd2 is actually cd7 antibody and respectively the product labelled as cd7 is cd2 antibody.